Dermata Therapeutics, Inc. (DRMA) financial statements and ratios from SEC XBRL: revenue $215041.00 (TTM), net margin -3514.9%, revenue growth -4.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $215041.00 |
| Net Margin | -3514.9% |
| Revenue Growth (YoY) | -4.8% |
| EPS Growth (YoY) | 1.6% |
| Price / Book | 1.63 |
| Price / Sales | 20.81 |
| FCF Yield | -88.4% |
| Sector P/E (Healthcare) | 21.7 |
DRMA overview · DRMA earnings · DRMA KPIs · DRMA investor relations · DRMA ownership · DRMA peers · DRMA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.